This interview features Dr. Xiaolong Qi, a recipient of the Huaxia Youth Medical Science and Technology Award, one of the most prestigious awards in the Chinese medical field. The Huaxia Medical Science and Technology Award, approved by the Ministry of Science and Technology and the National Office for Science and Technology Awards, is a national award in the medical and health field hosted by the China International Exchange and Promotive Association for Medical and Health Care. In 2023, the award included five categories, with the Huaxia Youth Medical Science and Technology Award being a significant one, highlighting young scholars under 45.
Dr. Xiaolong Qi, a young scholar in the field of hepatology, discusses his experience and contributions that led to this honor. He attributes his success to focusing on the non-invasive diagnosis of portal hypertension due to liver cirrhosis, a key scientific issue, over the past 15 years. His work involved original innovation and application in terms of new technologies, standards, and products, aligning with the award’s criteria of recognizing young scholars for their significant, original, and serial achievements.
Dr. Xiaolong Qi has led the development of the Chinese Portal Hypertension Alliance (CHESS), an international platform for clinical research and translational science in portal hypertension and liver cirrhosis. Under his leadership, CHESS has initiated 39 multicenter clinical studies domestically and internationally, gaining support from over 500 high-level hospitals in China and fostering collaborations with academic organizations in over 20 countries. Furthermore, CHESS has established the first English journal focused on portal hypertension and liver cirrhosis, “Portal Hypertension & Cirrhosis,” managed by the Chinese Association for Science and Technology and hosted by the Chinese Medical Association.
As the first scholar in the hepatology field to receive this award, Dr. Xiaolong Qi shares his insights on the importance of focusing on specific scientific problems and maintaining a concentrated academic network. He emphasizes the principle of “Less is More,” advising young scholars to focus on their field’s history, current status, and unresolved issues. To support young hepatologists under 35, CHESS, in collaboration with the National Center for Infectious Diseases, has launched the “Qinggan Scholar” program, providing a platform for academic exchange and development.
Dr. Xiaolong Qi, a distinguished young scholar recognized by the Ministry of Education and the director of the Portal Hypertension Center at Zhongda Hospital Affiliated with Southeast University, is also the founder and head of CHESS and PH&C.
Expert Profile
Xiaolong Qi
Ministry of Education ‘Yangtze River Scholar’ Young Scholar, Assistant to the President of Zhongda Hospital affiliated with Southeast University, Director of the Portal Hypertension Center, Founder of CHESS, and Principal Commissioner of the Alliance, Founder of PH&C.”
TAG: Interview; Huaxia Youth Medical Science and Technology Award; portal hypertension
